284 related articles for article (PubMed ID: 28237084)
21. Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis.
Marchand NE; Choi MY; Oakes EG; Cook NR; Stevens E; Gomelskaya N; Kotler G; Manson JE; Lasky-Su J; Mora S; Lee IM; Tatituri R; Costenbader KH
Prostaglandins Leukot Essent Fatty Acids; 2023 Mar; 190():102542. PubMed ID: 36773395
[TBL] [Abstract][Full Text] [Related]
22. The biosynthetic pathways of the protectins.
Stenvik Haatveit Å; Hansen TV
Prostaglandins Other Lipid Mediat; 2023 Dec; 169():106787. PubMed ID: 37806439
[TBL] [Abstract][Full Text] [Related]
23. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis.
Eickmeier O; Fussbroich D; Mueller K; Serve F; Smaczny C; Zielen S; Schubert R
PLoS One; 2017; 12(2):e0171249. PubMed ID: 28158236
[TBL] [Abstract][Full Text] [Related]
24. Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation.
Motwani MP; Colas RA; George MJ; Flint JD; Dalli J; Richard-Loendt A; De Maeyer RP; Serhan CN; Gilroy DW
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563331
[TBL] [Abstract][Full Text] [Related]
25. Identification of proresolving and inflammatory lipid mediators in human psoriasis.
Sorokin AV; Norris PC; English JT; Dey AK; Chaturvedi A; Baumer Y; Silverman J; Playford MP; Serhan CN; Mehta NN
J Clin Lipidol; 2018; 12(4):1047-1060. PubMed ID: 29730187
[TBL] [Abstract][Full Text] [Related]
26. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.
Serhan CN; Chiang N; Dalli J
Mol Aspects Med; 2018 Dec; 64():1-17. PubMed ID: 28802833
[TBL] [Abstract][Full Text] [Related]
27. Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis.
Zhu M; Wang X; Hjorth E; Colas RA; Schroeder L; Granholm AC; Serhan CN; Schultzberg M
Mol Neurobiol; 2016 May; 53(4):2733-49. PubMed ID: 26650044
[TBL] [Abstract][Full Text] [Related]
28. Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells.
Ramon S; Gao F; Serhan CN; Phipps RP
J Immunol; 2012 Jul; 189(2):1036-42. PubMed ID: 22711890
[TBL] [Abstract][Full Text] [Related]
29. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators.
Dalli J; Serhan CN
Blood; 2012 Oct; 120(15):e60-72. PubMed ID: 22904297
[TBL] [Abstract][Full Text] [Related]
30. Specialized proresolving lipid mediators in humans with the metabolic syndrome after n-3 fatty acids and aspirin.
Barden AE; Mas E; Croft KD; Phillips M; Mori TA
Am J Clin Nutr; 2015 Dec; 102(6):1357-64. PubMed ID: 26561623
[TBL] [Abstract][Full Text] [Related]
31. Human milk proresolving mediators stimulate resolution of acute inflammation.
Arnardottir H; Orr SK; Dalli J; Serhan CN
Mucosal Immunol; 2016 May; 9(3):757-766. PubMed ID: 26462421
[TBL] [Abstract][Full Text] [Related]
32. High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation.
Weiss GA; Troxler H; Klinke G; Rogler D; Braegger C; Hersberger M
Lipids Health Dis; 2013 Jun; 12():89. PubMed ID: 23767972
[TBL] [Abstract][Full Text] [Related]
33. Lipid emulsion rich in n-3 polyunsaturated fatty acids elicits a pro-resolution lipid mediator profile in mouse tissues and in human immune cells.
Noureddine N; Hartling I; Wawrzyniak P; Srikanthan P; Lou PH; Lucchinetti E; Krämer SD; Rogler G; Zaugg M; Hersberger M
Am J Clin Nutr; 2022 Sep; 116(3):786-797. PubMed ID: 35849016
[TBL] [Abstract][Full Text] [Related]
34. Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation.
Recchiuti A; Serhan CN
Front Immunol; 2012; 3():298. PubMed ID: 23093949
[TBL] [Abstract][Full Text] [Related]
35. Effect of specialized pro-resolving lipid mediators in the regulation of vascular tone and inflammation in human saphenous vein.
Celik Z; Ozen G; Sunar S; Turkyilmaz S; Turkyilmaz G; Kavala AA; Teskin O; Dogan BSU; Topal G
Prostaglandins Other Lipid Mediat; 2023 Dec; 169():106786. PubMed ID: 37806440
[TBL] [Abstract][Full Text] [Related]
36. Metabolomics-lipidomics of eicosanoids and docosanoids generated by phagocytes.
Yang R; Chiang N; Oh SF; Serhan CN
Curr Protoc Immunol; 2011 Nov; Chapter 14():Unit 14.26. PubMed ID: 22048801
[TBL] [Abstract][Full Text] [Related]
37. Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediators.
Dahlke P; Peltner LK; Jordan PM; Werz O
Front Pharmacol; 2023; 14():1219160. PubMed ID: 37680719
[TBL] [Abstract][Full Text] [Related]
38. Effects of statins on specialized pro-resolving mediators: An additional pathway leading to resolution of inflammation.
Radbakhsh S; Katsiki N; Santos RD; Mikhailidis DP; Mantzoros CS; Sahebkar A
Metabolism; 2022 Jul; 132():155211. PubMed ID: 35533891
[TBL] [Abstract][Full Text] [Related]
39. Discovery of specialized pro-resolving mediators marks the dawn of resolution physiology and pharmacology.
Serhan CN
Mol Aspects Med; 2017 Dec; 58():1-11. PubMed ID: 28263773
[TBL] [Abstract][Full Text] [Related]
40. Specialized pro-resolving mediators as modulators of immune responses.
Julliard WA; Myo YPA; Perelas A; Jackson PD; Thatcher TH; Sime PJ
Semin Immunol; 2022 Jan; 59():101605. PubMed ID: 35660338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
